Tech Company Financing Transactions
Erasca Funding Round
Erasca, based in San Diego, received $18 million in investment from Andreessen Horowitz, Arch Venture Partners and Reneo Capital Management.
Transaction Overview
Company Name
Announced On
3/6/2019
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds of the financing will support the company's efforts to potentially in-license new investigational compounds in development, while also accelerating the buildout of Erasca's artificial intelligence (AI) platform that will drive discovery and development of a new generation of oncology drugs designed to not just treat, but actually cure, cancer.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10835 Rd. to the Cure 140
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Our mission at Erasca is embedded in our name: To erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology's hardest problems.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/6/2019: Zabo venture capital transaction
Next: 3/6/2019: Pantheon venture capital transaction
Share this article
News on VC Transactions
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs